EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

The Influenza‐Specific Immunoglobulin Repertoire – Nimble Yet Steeped in Tradition

Sarah F Andrews iD, Masaru Kanekiyo iD

Immunological Reviews · 2026

DOI: 10.1111/imr.70164 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Immunological Reviews, 2026. Verfasst von Sarah F Andrews und 1 weiteren Autor:innen. Beteiligte Einrichtung: Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA. Hauptthemen laut MEDLINE: Influenza, Human, Antibodies, Viral, Orthomyxoviridae, Influenza A virus. Die Arbeit nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Intramural Research Program of the National Institutes of Health (NIH), National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Influenza virus has circulated in the human population and co‐evolved with us for centuries or longer, shaping our immune repertoires through a continuous host–virus arms race. Across individuals, antibodies repeatedly converge on shared solutions for capturing this shape‐shifting virus by precisely targeting conserved sites of vulnerability—sites the virus cannot alter without functional cost—through structural features encoded directly by germline immunoglobulin genes. These recurring public antibodies, termed multi‐donor class antibodies, have been pivotal for understanding human anti‐influenza immunity and in guiding vaccine strategies that may shift the balance of the host–virus arms race. As single‐cell biology, structural biology, and computational approaches mature, previously uncharted areas of our immune repertoires are coming into view. Here, we review the current understanding of the influenza‐specific immune repertoire, focusing on antibodies and multi‐donor antibody classes directed toward antigenic supersites on viral hemagglutinin and neuraminidase—the two major targets of protective antibodies—and discuss how these insights may advance the development of game‐changing influenza vaccines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza, HumanAntibodies, ViralOrthomyxoviridaeInfluenza A virusHumansAnimalsInfluenza VaccinesNeuraminidaseHemagglutinin Glycoproteins, Influenza VirusAntigens, Viral

Stichwörter der Autor:innen

antibodieshemagglutinininfluenzamulti‐donor classneuraminidaserepertoirevaccine

Substanzen

Influenza VaccinesNeuraminidaseAntibodies, ViralHemagglutinin Glycoproteins, Influenza VirusAntigens, Viral

Autor:innen und Institutionen

  • Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

ORCID-Profile: Sarah F Andrews, Masaru Kanekiyo

Förderung

  • Intramural Research Program of the National Institutes of Health (NIH)
  • National Institutes of Health

Zitieren

APA

Andrews, S. F., & Kanekiyo, M. (2026). The Influenza‐Specific Immunoglobulin Repertoire – Nimble Yet Steeped in Tradition. Immunological Reviews. https://doi.org/10.1111/imr.70164

Vancouver

Andrews SF, Kanekiyo M. The Influenza‐Specific Immunoglobulin Repertoire – Nimble Yet Steeped in Tradition. Immunological Reviews. 2026. doi:10.1111/imr.70164

BibTeX
@article{Andrews2026,
  author = {Andrews, Sarah F and Kanekiyo, Masaru},
  title = {The Influenza‐Specific Immunoglobulin Repertoire – Nimble Yet Steeped in Tradition},
  journal = {Immunological Reviews},
  year = {2026},
  doi = {10.1111/imr.70164}
}
Kostenlos starten →